ANDA 81278, held by Teva Parenteral. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 81278 (Leucovorin Calcium), held by Teva Parenteral, was first approved by FDA on Sep 28, 1993, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 28, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 50MG BASE/VIAL ยท injectable;injection | Leucovorin Calcium | Discontinued |
| Dec 16, 1998 | Supplement 4Labeling | Approved | None posted |
| Apr 28, 1998 | Supplement 3Labeling | Approved | None posted |
| Nov 10, 1997 | Supplement 2Labeling | Approved | None posted |
| May 20, 1996 | Supplement 1Labeling | Approved | None posted |
| Sep 28, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters